PET Study of [18F]6-Fluoro-l-Dopa Uptake in Neuroleptic- and Mood-Stabilizer-Naive First-Episode Nonpsychotic Mania: Effects of Treatment With Divalproex Sodium
Abstract
OBJECTIVE: Although dopaminergic hyperactivity has been implicated in mania, the precise location in the brain of the abnormality is unclear. This study assessed presynaptic dopamine function in neuroleptic- and mood-stabilizer-naive nonpsychotic first-episode manic patients before and after treatment with divalproex sodium by measuring [(18)F]6-fluoro-L-dopa ([(18)F]DOPA) uptake in the striatum with positron emission tomography (PET). METHOD: Thirteen patients with DSM-IV bipolar I disorder, manic episode, and 13 healthy comparison subjects underwent [(18)F]DOPA PET scans. Ten of the 13 patients had repeat PET scans 2-6 weeks after beginning treatment with divalproex sodium monotherapy. [(18)F]DOPA uptake rate constants (K(i) values) in the striatum were calculated by using graphical analysis with activity from the occipital cortex as the input function. RESULTS: No significant differences in [(18)F]DOPA uptake rate constants in the striatum were found between the manic patients and the comparison subjects. After treatment with divalproex sodium, [(18)F]DOPA rate constants were significantly reduced in the patients and were lower in the patients than in the comparison subjects. CONCLUSIONS: Although presynaptic dopamine function as reflected by [(18)F]DOPA uptake is not altered in mania, presynaptic dopamine function in manic patients was lower after treatment with divalproex sodium.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The presence of psychosis may moderate patterns of DA receptor binding; striatal D2 receptor signaling seems greater in psychotic patients with bipolar disorder, whereas no differences in D2 availability were found between non-psychotic patients with bipolar disorder and controls.
“There is also evidence that the presence of psychosis may moderate patterns of DA receptor binding. Specifically, striatal D2 receptor signaling seems to be greater in psychotic patients with bipolar disorder [286,287], whereas no differences in D2 availability were found between non-psychotic patients with bipolar disorder and controls [288,289].”
From Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings (2012) · cites this paper as [289]
Cites
A Rating Scale for Mania: Reliability, Validity and Sensitivity
Young, R. C., Biggs, J. T., Ziegler, V. E., & Meyer, D. A. (1978) · British Journal of Psychiatry · doi:10.1192/bjp.133.5.429 · Cited by 8,744 · see citing works
Patlak, C. S., & Blasberg, R. G. (1985) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1985.87 · Cited by 1,673 · see citing works
Protein kinase recognition sequence motifs
Kemp, B. E., & Pearson, R. B. (1990) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(90)90073-k · Cited by 1,010 · see citing works
Positron Emission Tomography Reveals Elevated D 2 Dopamine Receptors in Drug-Naive Schizophrenics
Wong, D. F., Wagner, H. N., Tune, L. E., Dannals, R. F., Pearlson, G. D., Links, J. M., Tamminga, C. A., Broussolle, E., Ravert, H. T., Wilson, A. A., et al. (1986) · Science · doi:10.1126/science.2878495 · Cited by 928 · see citing works
D2 Dopamine Receptors in Neuroleptic-Naive Schizophrenic Patients
Farde, L. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810150013003 · Cited by 529 · see citing works
CSF and Urinary Biogenic Amines and Metabolites in Depression and Mania
Koslow, S. H. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790080081011 · Cited by 312 · see citing works
Nigrostriatal function in humans studied with positron emission tomography
Martin, W. R. W., Palmer, M. R., Patlak, C. S., & Calne, D. B. (1989) · Annals of Neurology · doi:10.1002/ana.410260407 · Cited by 282 · see citing works
Brooks, D. J., Salmon, É., Mathias, C. J., Quinn, N. P., Leenders, K. L., Bannister, R., MARSDEN, C. D., & Frackowiak, R. S. J. (1990) · Brain · doi:10.1093/brain/113.5.1539 · Cited by 256 · see citing works
Cerebrospinal Fluid Amine Metabolites in Affective Illness: The Probenecid Technique
Goodwin, F. K., Post, R. M., Dünner, D. L., & Gordon, E. K. (1973) · American Journal of Psychiatry · doi:10.1176/ajp.130.1.73 · Cited by 244 · see citing works
van Kammen, D. P., & Murphy, D. L. (1975) · Psychopharmacology · doi:10.1007/bf00428897 · Cited by 237 · see citing works
In Vivo D2 Dopamine Receptor Density in Psychotic and Nonpsychotic Patients With Bipolar Disorder
Pearlson, G. D. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950180057008 · Cited by 235 · see citing works
Brain SPECT Imaging of Amphetamine-Induced Dopamine Release in Euthymic Bipolar Disorder Patients
Anand, A., Verhoeff, P., Seneca, N., Zoghbi, S. S., Seibyl, J. P., Charney, D. S., & Innis, R. B. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.7.1108 · Cited by 222 · see citing works
Gerner, R. H., Fairbanks, L. A., Anderson, G. M., Young, J. G., Scheinin, M., Linnoila, M., Hare, T. A., Shaywitz, B. A., & Cohen, D. J. (1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.12.1533 · Cited by 212 · see citing works
The vesicular monoamine transporter is not regulated by dopaminergic drug treatments
Borght, T. V., Kilbourn, M. R., Desmond, T. J., Kuhl, D. E., & Frey, K. A. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00594-3 · Cited by 205 · see citing works
Cerebrospinal Fluid Amine Metabolites in Acute Schizophrenia
Post, R. M. (1975) · Archives of General Psychiatry · doi:10.1001/archpsyc.1975.01760260127011 · Cited by 204 · see citing works
Drug preference and mood in humans: d-amphetamine
Johanson, C. E., & UHLENHUTH, E. H. (1980) · Psychopharmacology · doi:10.1007/bf00433062 · Cited by 191 · see citing works
A dopaminergic mechanism in mania
Gerner, R. H., Post, R. M., & Bunney, W. E. (1976) · American Journal of Psychiatry · doi:10.1176/ajp.133.10.1177 · Cited by 144 · see citing works
Dopamine and mania: Behavioral and biochemical effects of the dopamine receptor blocker pimozide
Post, R. M., Jimerson, D. C., Bunney, W. E., & Goodwin, F. K. (1980) · Psychopharmacology · doi:10.1007/bf00431272 · Cited by 136 · see citing works
Cerebrospinal Fluid Levels of MHPG in Affective Disorders
Wilk, S., Shopsin, B., Gershon, S., & SUHL, M. (1972) · Nature · doi:10.1038/235440a0 · Cited by 123 · see citing works
Aromatic L‐Amino Acid Decarboxylase Activity of Mouse Striatum Is Modulated via Dopamine Receptors
Hadjiconstantinou, M., Wemlinger, T. A., Sylvia, C.-H., Hubble, J. P., & Neff, N. H. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03503.x · Cited by 118 · see citing works
5-Hydroxyindolacetic acid and homovanillic acid in cerebrospinal fluid in manic-depressive psychosis
Sj�str�m, R., & Roos, B. E. (1972) · European Journal of Clinical Pharmacology · doi:10.1007/bf00561141 · Cited by 116 · see citing works
Regulation of Aromatic l ‐Amino Acid Decarboxylase by Dopamine Receptors in the Rat Brain
Zhu, M., Juorio, A. V., Paterson, I. A., & Boulton, A. A. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb09765.x · Cited by 114 · see citing works
Brodie, H. K. H., Murphy, D. L., Goodwin, F. K., & Bunney, W. E. (1971) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1971122part1218 · Cited by 100 · see citing works
Biogenic amine metabolites in cerebrospinal fluid of patients with affective disorders
Vestergaard, P., Sørensen, T., Hoppe, E., Rafaelsen, O. J., Yates, C. M., & Nicolaou, N. (1978) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1978.tb06924.x · Cited by 100 · see citing works
Zubieta, J., Huguelet, P., Ohl, L. E., Koeppe, R. A., Kilbourn, M. R., Carr, J. M., Giordani, B., & Frey, K. A. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.10.1619 · Cited by 93 · see citing works
Nürnberger, J. I., Gershon, E. S., Simmons, S., Ebert, M. H., Kessler, L. R., Dibble, E. D., Jimerson, S. S., Brown, G. M., Gold, P. W., Jimerson, D. C., et al. (1982) · Psychoneuroendocrinology · doi:10.1016/0306-4530(82)90009-9 · Cited by 93 · see citing works
Bánki, C. M. (1977) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1977.tb07739.x · Cited by 91 · see citing works
Neuroendocrine and amine studies in affective illness
Casper, R. C., Davis, J. M., Pandey, G. N., Garver, D. L., & Dekirmenjian, H. (1977) · Psychoneuroendocrinology · doi:10.1016/0306-4530(77)90016-6 · Cited by 84 · see citing works
Recent Advances in Treatment of Acute Mania
CHOU, J. C. Y. (1991) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199102000-00002 · Cited by 82 · see citing works
Cerebrospinal Fluid Amine Metabolites
Redmond, D. E. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800100028005 · Cited by 78 · see citing works
Amphetamine metabolism in amphetamine psychosis
Änggård, E., Jônsson, L.-E., Hogmark, A.-L., & Gunne, L. (1973) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1973145870 · Cited by 76 · see citing works
CSF monoamine metabolites in mania
Swann, A. C., Secunda, S. K., Davis, J. M., Robins, E., Hanin, I., Koslow, S. H., & Maas, J. W. (1983) · American Journal of Psychiatry · doi:10.1176/ajp.140.4.396 · Cited by 76 · see citing works
Routine synthesis of L-[18F]6-fluorodopa with fluorine-18 acetyl hypofluorite.
Adam, M. J., Ruth, T. J., Grierson, J. R., Abeysekera, B., & Pate, B. D. (1986) · PubMed · Cited by 75 · see citing works
Self-citationGJEDDE, A. H., Léger, G. C., Cumming, P. D., Yasuhara, Y., Evans, A. C., Guttman, M., & Kuwabara, H. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb13651.x · Cited by 75 · see citing works
Reproducibility of fluorine-18-6-fluorodopa positron emission tomography in normal human subjects.
Vingerhoets, F. J. G., Snow, B. J., Schulzer, M., Morrison, S., Ruth, T. J., Holden, J. E., Cooper, S. D., & Calne, D. B. (1994) · PubMed · Cited by 73 · see citing works
Self-citationGarnett, E. S., Firnau, G., Chan, P. K. H., Sood, S. K., & Belbeck, L. W. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.1.464 · Cited by 71 · see citing works
Vlissides, D. N., Gill, D., & Castelow, J. (1978) · BMJ · doi:10.1136/bmj.1.6111.510-a · Cited by 70 · see citing works
RESPONSE TO BROMOCRIPTINE DISTINGUISHES BIPOLAR FROM UNIPOLAR DEPRESSION
Silverstone, T. (1984) · The Lancet · doi:10.1016/s0140-6736(84)91359-x · Cited by 66 · see citing works
Double‐blind comparative clinical trial of pimozide and chlorpromazine in mania
Cookson, J., Silverstone, T., & Wells, B. (1981) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1981.tb00797.x · Cited by 58 · see citing works
Inhibition of Dopamine-B-Hydroxylase in Manic Patients
Sack, R. L. (1974) · Archives of General Psychiatry · doi:10.1001/archpsyc.1974.01760170049008 · Cited by 56 · see citing works
Cumming, P. D., Häusser, M., Martin, W. R. W., Grierson, J. R., Adam, M. J., Ruth, T. J., & McGeer, E. G. (1988) · Biochemical Pharmacology · doi:10.1016/0006-2952(88)90725-3 · Cited by 53 · see citing works
Self-citationBiological imaging and the molecular basis of dopaminergic diseases
Barrio, J. R., Huang, S. C., & Phelps, M. E. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00031-2 · Cited by 53 · see citing works
Silverstone, T., Fincham, J., Wells, B., & Kyriakides, M. (1980) · Neuropharmacology · doi:10.1016/0028-3908(80)90215-4 · Cited by 44 · see citing works
Sj�str�m, R. (1973) · European Journal of Clinical Pharmacology · doi:10.1007/bf00562430 · Cited by 43 · see citing works
Brook, N., & Cookson, I. B. (1978) · BMJ · doi:10.1136/bmj.1.6115.790-a · Cited by 40 · see citing works
Neuroendocrine evaluation of catecholaminergic neurotransmission in mania
Ansseau, M., von Frenckell, R., Cerfontaine, J.-L., Papart, P., Franck, G., Timsit-Berthier, M., Geenen, V. G., & Legros, J. (1987) · Psychiatry Research · doi:10.1016/0165-1781(87)90034-5 · Cited by 39 · see citing works
Is There a Common Denominator for the Antimanic Effect of Lithium and Anticonvulsants?
Waldmeier, P. C. (1987) · Pharmacopsychiatry · doi:10.1055/s-2007-1017072 · Cited by 38 · see citing works
Deep, P., GJEDDE, A. H., & Cumming, P. D. (1997) · Journal of Neuroscience Methods · doi:10.1016/s0165-0270(97)00094-0 · Cited by 35 · see citing works
Haloperidol and lithium blocking of the mood response to intravenous methylphenidate
Wald, D., Ebstein, R. P., & Belmaker, R. H. (1978) · Psychopharmacology · doi:10.1007/bf00426962 · Cited by 34 · see citing works
Nolen, W. A. (1983) · Journal of Affective Disorders · doi:10.1016/0165-0327(83)90001-0 · Cited by 31 · see citing works
L-dopa, behavioral activation and psychopathology.
Dl, M. (1972) · PubMed · Cited by 30 · see citing works
Silverstone, T., Wells, B., & Trenchard, E. (1983) · Psychopharmacology · doi:10.1007/bf00427820 · Cited by 25 · see citing works
Amphetamine-Induced Dysphoria in Postmenopausal Women
Halbreich, U. M., Asnis, G. M., Ross, D. C., & Endicott, J. (1981) · The British Journal of Psychiatry · doi:10.1192/bjp.138.6.470 · Cited by 24 · see citing works
Amphetamine and vigabatrin down regulate aromatic l-amino acid decarboxylase mRNA levels
Buckland, P. R., Spurlock, G., & McGuffin, P. (1996) · Molecular Brain Research · doi:10.1016/0169-328x(95)00182-r · Cited by 22 · see citing works
Interaction of fenfluramine with d-amphetamine-induced excitatory behaviour and hyperthermia
Jonsson, J., & Gunne, L. M. (1972) · European Journal of Pharmacology · doi:10.1016/0014-2999(72)90076-3 · Cited by 15 · see citing works
Mb, B. (1976) · PubMed · Cited by 12 · see citing works
Growth hormone response and central aminergic systems in affective diseases [proceedins].
Dl, G., Gn, P., Hengeveld, C. A., & Jm, D. (1977) · PubMed · Cited by 10 · see citing works
Flagged first, then by citations
1 of the 58 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
Howes, O. D., & Kapur, S. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp006 · Cited by 2,693 · see citing works
The functional neuroanatomy of bipolar disorder: a review of neuroimaging findings
Strakowski, S. M., DelBello, M. P., & Adler, C. M. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001585 · Cited by 818 · see citing works
Elevated Striatal Dopamine Function Linked to Prodromal Signs of Schizophrenia
Howes, O. D., Montgomery, A. J., Asselin, M.-C., Murray, R. M., Valli, I., Tabraham, P., Bramon-Bosch, E., Valmaggia, L., Johns, L., Broome, M., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2008.514 · Cited by 744 · see citing works
Ashok, A. H., Marques, T. R., Jauhar, S., Nour, M. M., Goodwin, G. M., Young, A. H., & Howes, O. D. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.16 · Cited by 546 · see citing works
Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder
Berk, M., Dodd, S., Kauer‐Sant’Anna, M., Malhi, G. S., Bourin, M., Kapczinski, F., & Norman, T. (2007) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2007.01058.x · Cited by 396 · see citing works
Dichter, G. S., Damiano, C. A., & Allen, J. A. (2012) · Journal of Neurodevelopmental Disorders · doi:10.1186/1866-1955-4-19 · Cited by 299 · see citing works
The role of dopamine in bipolar disorder
Cousins, D. A., Butts, K. A., & Young, A. H. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00760.x · Cited by 286 · see citing works
A review of brain oscillations in cognitive disorders and the role of neurotransmitters
Başar, E., & Güntekin, B. (2008) · Brain Research · doi:10.1016/j.brainres.2008.06.103 · Cited by 269 · see citing works
Striatal Presynaptic Dopamine in Schizophrenia, Part II: Meta-Analysis of [18F/11C]-DOPA PET Studies
Fusar‐Poli, P., & Meyer‐Lindenberg, A. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr180 · Cited by 257 · see citing works
Frey, B. N., Valvassori, S. S., Réus, G. Z., Martins, M. R., Petronilho, F. C., Bardini, K., Dal‐Pizzol, F., Kapczinski, F. P., & Quevedo, J. (2006) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0637 · Cited by 238 · see citing works
Jauhar, S., Nour, M. M., Veronese, M., Rogdaki, M., Bonoldi, I., Azis, M., Turkheimer, F., McGuire, P., Young, A. H., & Howes, O. D. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.2943 · Cited by 233 · see citing works
A review of gamma oscillations in healthy subjects and in cognitive impairment
Başar, E. (2013) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2013.07.005 · Cited by 190 · see citing works
The underlying neurobiology of bipolar disorder.
Manji, H. K., Quiroz, J. A., Payne, J. L., Singh, J., Lopes, B. P., Viegas, J. S., & Zarate, C. A. (2003) · Europe PMC (PubMed Central) · Cited by 160 · see citing works
Atypical antipsychotics in bipolar depression: potential mechanisms of action.
Yatham, L. N., Goldstein, J. M., Vieta, E., Bowden, C. L., Grunze, H., Post, R. M., Suppes, T. M., & Calabrese, J. R. (2005) · PubMed · Cited by 159 · see citing works
Self-citationBrain Imaging Studies in Mood and Anxiety Disorders
Anand, A., & Shekhar, A. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07095.x · Cited by 155 · see citing works
Functional neuroimaging in schizophrenia: diagnosis and drug discovery.
McGuire, P., Howes, O., Stone, J., & Fusar-Poli, P. (2008) · TIPS - Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.11.005 · Cited by 160 · see citing works
Pre-synaptic striatal dopaminergic function in people at high risk of psychosis
Howes, O., Montgomery, A., Asselin, M., Murray, R., Grasby, P., & McGuire, P. (2007) · The British journal of psychiatry. Supplement · doi:10.1192/bjp.191.51.s13 · Cited by 159 · see citing works
Anand, A., Barkay, G., Dzemidzic, M., Albrecht, D., Karne, H., Zheng, Q.-H., Hutchins, G. D., Normandin, M. D., & Yoder, K. K. (2011) · Bipolar Disorders · doi:10.1111/j.1399-5618.2011.00936.x · Cited by 139 · see citing works
PET Studies of Cerebral Levodopa Metabolism: A Review of Clinical Findings and Modeling Approaches
Kumakura, Y., & Cumming, P. D. (2009) · The Neuroscientist · doi:10.1177/1073858409338217 · Cited by 132 · see citing works
A review of valproate in psychiatric practice
Haddad, P. M., Das, A. K., Ashfaq, M., & Wieck, A. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250902911455 · Cited by 135 · see citing works
Nikolaus, S., Antke, C., & Müller, H. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.06.009 · Cited by 125 · see citing works
Incentive‐elicited mesolimbic activation and externalizing symptomatology in adolescents
Bjork, J. M., Chen, G., Smith, A. R., & Hommer, D. W. (2010) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2009.02201.x · Cited by 120 · see citing works
Basal Ganglia Shape Alterations in Bipolar Disorder
Hwang, J., Lyoo, I. K., Dager, S. R., Friedman, S. D., Oh, J. S., Lee, J., Kim, S. J., Dünner, D. L., & Renshaw, P. F. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.2.276 · Cited by 111 · see citing works
Gründer, G., Vernaleken, I., Müller, M. J., Davids, E., Heydari, N., Buchholz, H., Bartenstein, P., Munk, O. L., Stoeter, P., Wong, D. F., et al. (2002) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300103 · Cited by 111 · see citing works
PET evidence for a role of the basal ganglia in patients with ring chromosome 20 epilepsy
Biraben, A., Semah, F., Ribeiro, M.-J., Douaud, G., Rémy, P., & Depaulis, A. (2004) · Neurology · doi:10.1212/01.wnl.0000132840.40838.13 · Cited by 103 · see citing works
Increased striatal dopamine (D2/D3) receptor availability and delusions in Alzheimer disease
Reeves, S., Brown, R., Howard, R., & Grasby, P. (2009) · Neurology · doi:10.1212/01.wnl.0000341932.21961.f3 · Cited by 98 · see citing works
A functional magnetic resonance imaging study of cortical asymmetry in bipolar disorder
Caligiuri, M. P., Brown, G. G., Meloy, M. J., Eyler, L. T., Kindermann, S. S., Eberson, S., Frank, L. R., & Lohr, J. B. (2004) · Bipolar Disorders · doi:10.1111/j.1399-5618.2004.00116.x · Cited by 92 · see citing works
Striatal structure and function in mood disorders: a comprehensive review
Marchand, W. R., & Yurgelun‐Todd, D. (2010) · Bipolar Disorders · doi:10.1111/j.1399-5618.2010.00874.x · Cited by 91 · see citing works
Yatham, L., Liddle, P., Lam, R. W., Shiah, I., Lane, C. J., Stoessl, A., Sossi, V., & Ruth, T. J. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.10.1718 · Cited by 80 · see citing works
Self-citationLara, D. R., & Akiskal, H. H. (2006) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.03.021 · Cited by 79 · see citing works
Mazza, M., Nicola, M. D., Marca, G. D., Janiri, L., Bria, P., & Mazza, S. (2007) · The Neuroscientist · doi:10.1177/10738584070130041101 · Cited by 76 · see citing works
Controversies in bipolar disorder; role of second-generation antipsychotic for maintenance therapy
Jauhar, S., & Young, A. H. (2019) · International Journal of Bipolar Disorders · doi:10.1186/s40345-019-0145-0 · Cited by 77 · see citing works
Valproic Acid for Treatment of Hyperactive or Mixed Delirium: Rationale and Literature Review
Sher, Y. I., Cramer, A. C. M., Ament, A., Lolak, S., & Maldonado, J. R. (2015) · Psychosomatics · doi:10.1016/j.psym.2015.09.008 · Cited by 76 · see citing works
Jauhar, S., Veronese, M., Nour, M. M., Rogdaki, M., Hathway, P., Natesan, S., Turkheimer, F., Stone, J., Egerton, A., McGuire, P., et al. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.07.003 · Cited by 75 · see citing works
Dong, M.-X., Chen, G.-H., & Hu, L. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.608520 · Cited by 73 · see citing works
Classification of schizophrenic patients and healthy controls using [18F] fluorodopa PET imaging.
Bose, S., Turkheimer, F., Howes, O., Mehta, M., Cunliffe, R., Stokes, P. R. A., & Grasby, P. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.09.011 · Cited by 82 · see citing works
Avram, M., Brandl, F., Cabello, J., Leucht, C., Scherr, M., Mustafa, M., Leucht, S., Ziegler, S., & Sorg, C. (2019) · Brain : a journal of neurology · doi:10.1093/brain/awz093 · Cited by 63 · see citing works
Gönül, A. S., Coburn, K. L., & Kula, M. (2009) · International Review of Psychiatry · doi:10.1080/09540260902962131 · Cited by 67 · see citing works
Özerdem, A., Güntekin, B., Tunca, Z., & Başar, E. (2008) · Brain Research · doi:10.1016/j.brainres.2008.06.101 · Cited by 64 · see citing works
Chang, T. T., Yeh, T. L., Chiu, N. T., Chen, P. S., Huang, H. Y., Yang, Y. K., Lee, I. H., & Lu, R. B. (2010) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00771.x · Cited by 63 · see citing works
Neurochemical Underpinnings in Bipolar Disorder and Epilepsy
Amann, B. L., & Grunze, H. (2005) · Epilepsia · doi:10.1111/j.1528-1167.2005.463006.x · Cited by 49 · see citing works
Potential Therapeutic Role of Carnitine and Acetylcarnitine in Neurological Disorders
Maldonado, C., Vázquez, M., & Fagiolino, P. L. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200212114038 · Cited by 49 · see citing works
de Bartolomeis, A., Buonaguro, E. F., Iasevoli, F., & Tomasetti, C. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114523864 · Cited by 44 · see citing works
Adjunctive Valproic Acid in Management-Refractory Hyperactive Delirium: A Case Series and Rationale
Sher, Y. I., Miller, A. C., Lolak, S., Ament, A., & Maldonado, J. R. (2015) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.14080190 · Cited by 39 · see citing works
Lurasidone: a new treatment option for bipolar depression-a review.
Bawa, R., & Scarff, J. R. (2015) · Europe PMC (PubMed Central) · Cited by 38 · see citing works
Key players in major and bipolar depression—A retrospective analysis of in vivo imaging studies
Nikolaus, S., Hautzel, H., Heinzel, A., & Müller, H. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.03.021 · Cited by 35 · see citing works
Nikolaus, S., Mamlins, E., Hautzel, H., & Müller, H.-W. (2019) · Reviews in the Neurosciences · doi:10.1515/revneuro-2018-0037 · Cited by 35 · see citing works
The armamentarium of treatments for bipolar disorder: a review of the literature
Cousins, D. A., & Young, A. H. (2006) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145706007413 · Cited by 34 · see citing works
Abnormalities in Motor Physiology in Bipolar Disorder
Lohr, J. B., & Caligiuri, M. P. (2006) · Journal of Neuropsychiatry · doi:10.1176/jnp.2006.18.3.342 · Cited by 33 · see citing works
Varenicline-Induced Mania in a Bipolar Patient
Alhatem, F. J., & Black, J. (2009) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e31816f75bc · Cited by 32 · see citing works
Nikisch, G., Baumann, P., Wiedemann, G., Kießling, B., Weißer, H., Hertel, A., Yoshitake, T., Kehr, J., & Mathé, A. A. (2010) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181f2288e · Cited by 30 · see citing works
Toward Convergence in the Medication Treatment of Bipolar Disorder and Schizophrenia
Citrome, L., Goldberg, J. F., & Stahl, S. M. (2005) · Harvard Review of Psychiatry · doi:10.1080/10673220590923164 · Cited by 29 · see citing works
Yatham, L. N., Liddle, P. F., Gonzalez, M., Saraf, G., Vafai, N. M., Lam, R. W. M., & Sossi, V. (2022) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2022.3541 · Cited by 26 · see citing works
Self-citationFunctional illness in primary care: dysfunction versus disease
Williams, N. H., Wilkinson, C., Stott, N., & Menkes, D. B. (2008) · BMC Family Practice · doi:10.1186/1471-2296-9-30 · Cited by 27 · see citing works
Young, A. H. (2014) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000020 · Cited by 25 · see citing works
Molecular imaging in patients with mood disorders: a review of PET findings
Chen, Q., Liu, W., Li, H., Zhang, H., & Tian, M. (2011) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-011-1779-z · Cited by 25 · see citing works
Positron‐labeled DOPA analogs to image dopamine terminals
DeJesus, O. T. (2003) · Drug Development Research · doi:10.1002/ddr.10223 · Cited by 23 · see citing works
Bonoldi, I., & Howes, O. (2013) · Advances in Pharmacology · doi:10.1016/b978-0-12-411512-5.00010-5 · Cited by 16 · see citing works
Changes in striatal dopamine transporters in bipolar disorder and valproate treatment
Hsueh, Y., Lin, C.-Y., Chiu, N.-T., Yang, Y. K., Chen, P. S., & Chang, H. H. (2021) · European Psychiatry · doi:10.1192/j.eurpsy.2021.1 · Cited by 17 · see citing works
Evidence of astrogliosis in rat hippocampus after d-amphetamine exposure
Frey, B. N., Andreazza, A. C., Ceresér, K. M., Martins, M. R., Petronilho, F. C., de Souza, D. F., Tramontina, F. F., Gonçalves, C. A., Quevedo, J., & Kapczinski, F. P. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.03.016 · Cited by 17 · see citing works
Grunze, H. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-398270-4.00040-9 · Cited by 16 · see citing works
Badawy, A. A. ‐. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3191-9 · Cited by 15 · see citing works
Fou rire prodromique and history of pathological laughter in the XIXth and XXth centuries
Gondim, F. D. A. A., Thomas, F. P., de Oliveira, G. R., & Cruz‐Flores, S. (2004) · Revue Neurologique · doi:10.1016/s0035-3787(04)70902-9 · Cited by 13 · see citing works
Neuroreceptor Imaging of Stress and Mood Disorders
Kennedy, S. E., & Zubieta, J.-K. (2004) · CNS Spectrums · doi:10.1017/s1092852900009238 · Cited by 12 · see citing works
Translating knowledge of genetics and pharmacology into improving everyday practice
Yatham, L. N. (2005) · Bipolar Disorders · doi:10.1111/j.1399-5618.2005.00211.x · Cited by 12 · see citing works
Self-citationMolecular Imaging of Depressive Disorders
Ruhé, H., Visser, A. K. D., Frokjaer, V., Haarman, B., Klein, H., & Booij, J. (2020) · PET and SPECT in Psychiatry · doi:10.1007/978-3-642-40384-2_5 · Cited by 2 · see citing works
Normalization of risperidone-induced hyperprolactinemia with the addition of aripiprazole.
Shores, L. E. (2005) · PubMed Central · Cited by 11 · see citing works
The treatment of bipolar mixed states
Cookson, J., & Ghalib, S. (2005) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544019.016 · Cited by 11 · see citing works
Neurochemical brain imaging studies in bipolar disorder
Yatham, L. N., & Malhi, G. S. (2003) · Acta Neuropsychiatrica · doi:10.1046/j.1601-5215.2003.00053.x · Cited by 10 · see citing works
Self-citationChang, W. H., Chen, K. C., Lee, I. H., Chi, M. H., Chen, P. S., Yao, W. J., Chiu, N.-T., & Yang, Y. K. (2016) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000632 · Cited by 8 · see citing works
Clinical neuroimaging markers of response to treatment in mood disorders
Porcu, M., Balestrieri, A., Siotto, P., Lucatelli, P., Anzidei, M., Suri, J. S., Zaccagna, F., Argiolas, G. M., & Saba, L. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.10.013 · Cited by 8 · see citing works
Presynaptic Dopaminergic Function: Implications for Understanding Treatment Response in Psychosis
Bonoldi, I., & Howes, O. (2014) · CNS Drugs · doi:10.1007/s40263-014-0177-z · Cited by 9 · see citing works
Alterations in Gene Expression in Depression
Donev, R., & Alawam, K. (2015) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2015.07.005 · Cited by 6 · see citing works
Stimulants for Treating Bipolar Disorder
Grunze, H. (2014) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000003 · Cited by 6 · see citing works
Abnormalities in Catecholamines and the Pathophysiology of Bipolar Disorder
Garakani, A., Charney, D. S., & Anand, A. (2007) · CRC Press eBooks · doi:10.3109/9781420021158-6 · Cited by 6 · see citing works
An Overview of Machine Learning Applications in Mood Disorders
Topolski, N., Jeong, S. H., & Mwangi, B. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.017 · Cited by 4 · see citing works
Molecular Imaging of Depressive Disorders
Ruhé, H. G., Frøkjær, V. G., Haarman, B. C. M., Jacobs, G. E., & Booij, J. (2020) · Springer eBooks · doi:10.1007/978-3-030-57231-0_4 · Cited by 3 · see citing works
Neurotransmitter Systems in Bipolar Disorder
Nakic, M., Krystal, J. H., & Bhagwagar, Z. (2010) · doi:10.1002/9780470661277.ch16 · Cited by 4 · see citing works
Saraf, G., Pinto, J. V., Cahn, A. J., White, A. G., Shahinfard, E., Vafai, N. M., Sossi, V., & Yatham, L. N. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.08.022 · Cited by 3 · see citing works
Self-citationHaarman, B. C. M., der Lek, R. F. R., Ruhé, H. G., de Groot, J. C., Nolen, W. A., & Doorduin, J. (2014) · Springer eBooks · doi:10.1007/978-3-642-40384-2_9 · Cited by 3 · see citing works
(2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018 · Cited by 3 · see citing works
Delvecchio, G., Maggioni, E., Squarcina, L., Arighi, A., Galimberti, D., Scarpini, E. A., Bellani, M., & Brambilla, P. (2020) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-020-00204-7 · Cited by 3 · see citing works
Dopamine docking studies of biologically active metabolites from Curcuma longa L.
Bernardi, D. M., Marchi, J. P., Araújo, C. D. S. A., do Nascimento, V. R., Lima, D. D. S., Wietzikoski, S., Ferro, M. M., Miyoshi, E., Lívero, F. A. D. R., Seixas, F. A. V., et al. (2021) · Research Society and Development · doi:10.33448/rsd-v10i7.16992 · Cited by 4 · see citing works
Neuroimaging Studies of Effects of Psychotherapy in Depression
Bauer, I. E., & Meyer, T. D. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.021 · Cited by 2 · see citing works
Sano, Y., Yamamoto, Y., Kubota, M., Moriguchi, S., Matsuoka, K., Kurose, S., Tagai, K., Endo, H., Yamagata, B., Suzuki, H., et al. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03107-3 · Cited by 2 · see citing works
Dopamine and Response to Antipsychotic Medication
Ntephe, C., & Demjaha, A. (2020) · Springer eBooks · doi:10.1007/978-3-030-57231-0_14 · Cited by 2 · see citing works
Electrophysiological Biomarkers for Mood Disorders
Ramakrishnan, N., Murphy, N., Selvaraj, S., & Cho, R. Y. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.015 · Cited by 2 · see citing works
Abnormalities in Catecholamines and the Pathophysiology of Bipolar Disorder
Garakani, A., Charney, D. S., & Anand, A. (2007) · Medical psychiatry · doi:10.3109/9781420021158.003 · Cited by 2 · see citing works
Brain Imaging and the Mechanisms of Antidepressant Action
Godlewska, B. R., Selvaraj, S., & Cowen, P. J. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.020 · Cited by 1 · see citing works
Effects of Lithium on Brain Structure in Bipolar Disorder
Kaur, J., Kafantaris, V., & Szeszko, P. R. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.018 · Cited by 1 · see citing works
Functional Connectome in Bipolar Disorder
Cha, J., & Anand, A. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.008 · Cited by 1 · see citing works
Neuroimaging Data in Bipolar Disorder: An Updated View
Dell’Osso, B. M., Dobrea, C., Carlotta, M., Cremaschi, L., Arici, C., Benatti, B., & Carlo, A. (2012) · InTech eBooks · doi:10.5772/24566
Rolle des zentralen dopaminergen Systems bei psychiatrischen Erkrankungen
Abler, B., & Vasić, N. (2007) · Nervenheilkunde · doi:10.1055/s-0038-1626841
Fries, G. R. (2011) · Americanae (AECID Library)
Striatal Synaptosomal Dopamine and Serotonin Cross-talk Synthesis in Aging Rat
Mesripour, A. (2014) · International Neuropsychiatric Disease Journal · doi:10.9734/indj/2014/5681
de Moura, P. A., do Couto, F. S., Abreu, M., Vian, J., Moura, T., Frade, P., & Levy, P. (2015)
Brain Imaging Studies in Bipolar Disorder
Monkul, E. S., Brambilla, P., Nery, F. G., Hatch, J. P., & Soares, J. C. (2007) · CRC Press eBooks · doi:10.3109/9781420021158-12
Molecular imaging of major depression
Sacher, J., & Smith, G. S. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511782091.012
- Authors
- Yatham, L. N., Liddle, P. F., Shiah, I.-S., Lam, R. W., Ngan, E., Scarrow, G., Imperial, M., Stoessl, J., Sossi, V., & Ruth, T. J.
- Affiliations
- University of British Columbia (CA)
- Venue
- American Journal of Psychiatry
- Published
- 2002-05-01
- Volume
- 159
- Issue
- 5
- Pages
- 768-774
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2156766604
- Cited by
- 122
- References
- 58
- Citations by year
- 2024: 1 · 2022: 1 · 2021: 26 · 2020: 6 · 2019: 2 · 2018: 3 · 2017: 2 · 2016: 2 · 2015: 6 · 2014: 8 · 2013: 3 · 2012: 4
- FWCI
- 3.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Keywords
- first-episode mania, divalproex sodium, striatal dopamine uptake, bipolar I disorder, neuroleptic-naive patients
- MeSH terms
- Adult, Age Factors, Anticonvulsants, Bipolar Disorder, Corpus Striatum, Dihydroxyphenylalanine, Dopamine, Female, Fluorine Radioisotopes, Humans, Male, Middle Aged, Tomography, Emission-Computed, Antipsychotic Agents, Valproic Acid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review